SCHEMBL1960706

SCHEMBL1960706

CN(C)[C@H](C(=O)O)c1ccc(O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.46
ESR1 P03372 6/20 0.43
ESR2 Q92731 5/20 0.43
PDCD1 Q15116 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
DRD1 P21728 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
LMNA P02545 2/20 0.39
CYP1A2 P05177 1/20 0.39
PGR P06401 1/20 0.39
CHRM2 P08172 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
AR P10275 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CHRM1 P11229 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10933400 1.00 SRC (0.46) SRCESR1ESR2PDCD1CD274
SCHEMBL18920459 0.83 CHRNA7 (0.50) CYP2C19LMNAALDH1A1GAA
SCHEMBL18946105 0.83 CHRNA7 (0.50) CYP2C19LMNAALDH1A1GAA
SCHEMBL18920460 0.83 CHRNA7 (0.50) CYP2C19LMNAALDH1A1GAA
SCHEMBL222001 0.83 ALDH1A1 (0.51) SRCLMNACYP2D6ALDH1A1GAA
SCHEMBL628680 0.83 ALDH1A1 (0.51) SRCLMNACYP2D6ALDH1A1GAA
SCHEMBL10540988 0.83 ALDH1A1 (0.51) SRCLMNACYP2D6ALDH1A1GAA
SCHEMBL5184055 0.82 AOC3 (0.42) CYP2C19TDP1CYP1A2ALDH1A1GAA
SCHEMBL2089224 0.82 AOC3 (0.42) CYP2C19TDP1CYP1A2ALDH1A1GAA
SCHEMBL756439 0.82 AOC3 (0.42) CYP2C19TDP1CYP1A2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3377474-B1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2023-08-16 EP disclosed
US-20230133667-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2023-05-04 US disclosed
US-20230133817-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2023-05-04 US disclosed
US-11072635-B2 Macrocyclic broad spectrum antibiotics RQX PHARMACEUTICALS, INC. (US) 2021-07-27 US disclosed
US-20210198316-A9 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED (GB) 2021-07-01 US disclosed
EP-3145944-B1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2021-05-05 EP disclosed
US-20200239519-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. 2020-07-30 US disclosed
US-10392422-B2 Macrocyclic broad spectrum antibiotics RQX PHARMACEUTICALS, INC. (US) 2019-08-27 US disclosed
US-10351595-B2 2019-07-16 US disclosed
US-20170088582-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. (US) 2017-03-30 US disclosed
US-20110144376-A1 DERMATOLOGICAL AGENT SHOWA DENKO K.K. (JP) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351595-B2 MRPL21, PRSS1, PEPD SRC 1625/4885ESR1 861/4885ESR2 1463/4885
US-10392422-B2 Macrocyclic broad spectrum antibiotics MRPL21, PEPD, CTSC SRC 1844/4885ESR1 1058/4885ESR2 1424/4885
US-20110144376-A1 DERMATOLOGICAL AGENT POLR1C, TYR, MMP1 SRC 759/4885ESR1 2976/4885ESR2 3345/4885
US-20200239519-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC SRC 1844/4885ESR1 1058/4885ESR2 1424/4885
US-20230133817-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC SRC 1844/4885ESR1 1058/4885ESR2 1424/4885
US-20210198316-A9 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC SRC 1844/4885ESR1 1058/4885ESR2 1424/4885
US-20230133667-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC SRC 1844/4885ESR1 1058/4885ESR2 1424/4885
US-11072635-B2 Macrocyclic broad spectrum antibiotics MRPL21, PEPD, CTSC SRC 1844/4885ESR1 1058/4885ESR2 1424/4885
US-20170088582-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC SRC 1844/4885ESR1 1058/4885ESR2 1424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.